PTX:ASX
Prescient Therapeutics Ltd
A$0.066
0.00%
(0.00) 1D
Oct 2, 5:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.06
High
A$0.07
Low
A$0.06
Mkt. cap
75.49M
Avg. vol.
1.17M
Volume
1.35M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.06
High
A$0.07
Low
A$0.06
Mkt. cap
75.49M
Avg. vol.
1.17M
Volume
1.35M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
Traders Union
·
59 minutes ago
S&P500 has posted gains in nearly every November-through-June period since 1942, Lia Holmgren notes
InteractiveCrypto
·
6 hours ago
The S&P 500 Looks Strong. Underneath, October Looks Thin.
Forbes
·
8 hours ago
S&P 500 Q3 Earnings Preview: Trends Investors Need To Watch
TradingKey
·
17 hours ago
S&P 500 vs. Nasdaq 100: Which Is Better for Long-Term Investment?
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com